HemaCare Names Anna Stock Chief Operating Officer and Lisa Bacerra Chief Financial Officer

HemaCare Corporation (OTCBB:HEMA) today announced that it has named Anna Stock as Chief Operating Officer and Lisa Bacerra as Chief Financial Officer effective immediately.

During her 24 year tenure with HemaCare, Ms. Stock most recently held the position of Vice President of Operations.

Ms. Bacerra had been the Company's Corporate Controller since 2007. She previously served as Chief Financial Officer at Natren, Inc. and Senior Financial Manager at Prudential Healthcare of California.

Commenting on the appointments, Pete van der Wal, HemaCare’s President and CEO, stated, "I am delighted to have Anna and Lisa join the executive team. Their proven expertise and leadership skills will be invaluable in supporting further profitable growth for the Company.”

ABOUT HEMACARE CORPORATION

Founded in 1978, HemaCare collects, processes, and distributes blood products to hospital and research related organizations, provides cellular collection and other blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments to patients with a variety of disorders. HemaCare is licensed by the FDA and accredited by the AABB.